Registered Tanzania · TMDA

Nobivac® Rabies 10-Dose

Rabies virus inactivated antigen suspension ≥ 0,95 AIU* equivalent to ≥ 2,0 I.U.** ml

TAN 25 V 0484 Suspension for injection ≥ 0,95 AIU equivalent to ≥ 2.0 I.U

What it does

Antigens are substances that trigger an immune response in the body, helping to fight infections and diseases.

Commonly used for: to help the body recognize and fight infections, to assist in vaccine development

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TAN 25 V 0484
Registration date
2025-09-16
Expiry date
2030-09-15
Status
Registered/Compliant
Active ingredient
Rabies virus inactivated antigen suspension ≥ 0,95 AIU* equivalent to ≥ 2,0 I.U.** ml
Strength
≥ 0,95 AIU equivalent to ≥ 2.0 I.U
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Intervet
Country of origin
NETHERLANDS
Manufacturer location
Wim de Körverstraat 35, 5831 AN Boxmeer, Netherlands

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-03-11 23:45:59 · updated 2026-09-17 03:00:44

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About antigen

Antigens are substances that trigger an immune response in the body, helping to fight infections and diseases.

What it treats

  • to help the body recognize and fight infections
  • to assist in vaccine development

How it works

Antigens stimulate the immune system to produce antibodies, which are proteins that help protect the body from diseases.

Who it's for

Antigens are used for people needing vaccinations or treatments that enhance immune response.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About inactivated

Inactivated vaccines help your body build protection against certain diseases without causing the disease itself.

What it treats

  • prevention of infectious diseases

How it works

Inactivated vaccines contain viruses or bacteria that have been killed or inactivated, so they cannot cause disease. They stimulate your immune system to recognize and fight off the real infection if you are exposed in the future.

Who it's for

These vaccines are generally given to people of all ages, based on specific health recommendations.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About rabies

Rabies is a viral infection that affects the brain and spinal cord, usually transmitted through animal bites.

What it treats

  • protection against rabies after exposure
  • post-exposure prophylaxis for rabies

How it works

Rabies vaccines help your body build immunity against the rabies virus.

Who it's for

This treatment is for anyone who has been bitten by an animal that may carry rabies.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About virus

Viruses are microscopic organisms that can cause infections in humans, animals, and plants.

What it treats

  • viral infections
  • common cold
  • influenza (flu)
  • HIV/AIDS
  • hepatitis

How it works

Viruses invade living cells and use them to reproduce, which can lead to illness.

Who it's for

Viruses can affect anyone, but some groups, like those with weakened immune systems, are more at risk.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: antigen

Antigens are substances that can induce an immune response in the body. They are typically proteins or polysaccharides found on the surface of pathogens such as bacteria, viruses, and fungi, as well as on non-infectious substances like pollen and transplanted tissues. The immune system recognizes these antigens as foreign, leading to the production of antibodies and activation of immune cells.

Indications

  • Vaccination against infectious diseases
  • Allergy testing and immunotherapy
  • Monoclonal antibody production
  • Transplantation to prevent organ rejection

Dosage

Children: Dosing of antigens in children also depends on the specific antigen and the clinical indication. For pediatric vaccinations, refer to the BNF for Children.

Adults: Dosing of antigens is highly variable and depends on the specific antigen and the clinical indication. For vaccine administration, refer to national immunization guidelines.

Mechanism of action

Antigens work by binding to specific receptors on the surface of immune cells, such as B cells and T cells. This binding triggers a cascade of immune responses, including the proliferation of specific immune cell populations and the production of antibodies that target the antigen. This process is crucial for the development of adaptive immunity, allowing the body to remember and respond more effectively to future encounters with the same antigen.

Pharmacodynamics

The pharmacodynamics of antigens involve the interaction with the immune system to elicit a response. The magnitude and quality of this response can vary based on several factors, including the nature of the antigen, the route of exposure, and the host's immune status. Antigens can be classified as T-cell dependent or T-cell independent, influencing the type of immune response generated.

Pharmacokinetics

Antigens are processed by antigen-presenting cells (APCs) that present peptide fragments to T cells. The pharmacokinetics of antigens can vary widely depending on their form (e.g., live attenuated, inactivated, or subunit vaccines). Generally, once introduced into the body, antigens are taken up by APCs, which then migrate to lymph nodes to activate T and B cells. The duration of immune response can be influenced by the type of antigen and the presence of adjuvants.

Pregnancy

Safety during pregnancy depends on the specific type of antigen. Consult relevant guidelines for specific antigens.

Breast-feeding

Safety during breastfeeding varies by antigen type. Consult relevant guidelines for specific antigens.

Storage

Store at controlled room temperature, away from light and moisture. Specific storage conditions may vary based on the type of antigen.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: inactivated

Inactivated vaccines are a type of immunization that use pathogens that have been killed or inactivated through physical or chemical processes. Unlike live vaccines, inactivated vaccines do not replicate in the host but still stimulate an immune response. These vaccines are generally considered safe and are commonly used to prevent various infectious diseases.

Indications

  • Hepatitis A
  • Hepatitis B
  • Influenza
  • Polio
  • Rabies
  • Typhoid fever

Dosage

Children: Refer to specific product guidelines for paediatric dosing, as it varies by vaccine type and indication.

Adults: Refer to specific product guidelines for adult dosing, as it varies by vaccine type and indication.

Mechanism of action

Inactivated vaccines work by introducing a form of the pathogen that cannot cause disease into the body. This stimulates the immune system to produce antibodies and memory cells specific to the pathogen, allowing for a robust immune response upon future exposure. The immune system recognizes the inactivated pathogen as foreign, leading to the activation of T-cells and B-cells, which are crucial for long-term immunity.

Pharmacodynamics

The pharmacodynamics of inactivated vaccines involve the generation of an adaptive immune response. After vaccination, the body produces specific antibodies against the inactivated pathogen. The response typically includes both humoral immunity, characterized by antibody production, and cellular immunity, involving T-cell activation. The duration of immunity can vary, and booster doses may be required to maintain adequate protection.

Pharmacokinetics

Inactivated vaccines do not have a pharmacokinetic profile like traditional drugs since they do not enter systemic circulation in the same manner. Following administration, the vaccine components are taken up by antigen-presenting cells, which process and present the antigens to T-cells. The immune response is initiated locally at the site of injection and can be influenced by factors such as the route of administration and the presence of adjuvants that enhance the immune response.

Adverse effects

  • Injection site reactions (pain, swelling, redness)
  • Fever
  • Fatigue
  • Headache
  • Myalgia
  • Chills

Precautions

  • Assess for allergies to vaccine components
  • Monitor for allergic reactions post-administration
  • Consider underlying health conditions that may affect immune response

Pregnancy

Inactivated vaccines are generally considered safe during pregnancy, but individual risk-benefit assessment is recommended.

Breast-feeding

Inactivated vaccines can be administered during breastfeeding without concern for adverse effects in the infant.

Storage

Store in a refrigerator at 2°C to 8°C. Do not freeze.

Formulations

  • Inactivated viral vaccines
  • Inactivated bacterial vaccines

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: rabies

Rabies is a viral disease caused by the rabies virus, which primarily affects mammals, including humans. It is transmitted through the saliva of infected animals, commonly via bites. The disease is characterized by encephalitis and can lead to severe neurological symptoms, and is often fatal if not treated promptly. Vaccination is a critical preventive measure, particularly for individuals at high risk of exposure, such as veterinary staff and travelers to endemic areas.

Indications

  • Rabies prevention in individuals at high risk of exposure
  • Post-exposure prophylaxis following potential rabies exposure
  • Vaccination for travelers to endemic regions

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations for pediatric patients.

Adults: Refer to the BNF for specific dosing guidelines, as it varies based on exposure risk and vaccination history.

Mechanism of action

The rabies vaccine works by stimulating the immune system to produce antibodies against the rabies virus. This is achieved through the introduction of inactivated or attenuated virus particles, which mimic the infection without causing the disease. The immune response generated helps to prevent the virus from causing illness upon subsequent exposure.

Pharmacodynamics

The rabies vaccine induces an adaptive immune response, leading to the production of neutralizing antibodies specific to the rabies virus. This immune memory protects against future infections. The vaccine is typically administered in a series of doses to ensure adequate immune response and long-term protection.

Pharmacokinetics

The pharmacokinetics of the rabies vaccine involve absorption at the injection site, followed by systemic distribution of the antigens. The onset of immunity generally occurs within two weeks after the initial vaccination, with peak antibody levels typically reached within one to two months. The duration of immunity can vary, necessitating booster doses in certain populations.

Interactions

  • chloroquine+rabiesvaccine: Severe (decreases efficacy)

Pregnancy

Rabies vaccination is generally considered safe during pregnancy. However, the risks and benefits should be carefully evaluated.

Breast-feeding

Rabies vaccine is not known to cause any adverse effects in breastfeeding. However, consult with a healthcare provider for individual assessments.

Storage

Store the rabies vaccine in a refrigerator at 2-8 degrees Celsius. Do not freeze.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: virus

Viruses are submicroscopic infectious agents that replicate only inside the living cells of an organism. They are composed of genetic material (either DNA or RNA) surrounded by a protein coat and, in some cases, an outer lipid envelope. Viruses can infect all types of life forms, from animals and plants to microorganisms, including bacteria (bacteriophages). They are responsible for a wide range of diseases, from the common cold to serious conditions such as HIV/AIDS, influenza, and COVID-19.

Indications

  • Influenza
  • HIV/AIDS
  • Hepatitis B and C
  • Herpes simplex virus infections
  • Cytomegalovirus infections
  • COVID-19
  • Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.